Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Grows By 96.6%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 9,443 shares, a growth of 96.6% from the June 30th total of 4,802 shares. Based on an average daily volume of 54,956 shares, the short-interest ratio is currently 0.2 days.

Alpha Tau Medical Stock Performance

Shares of NASDAQ:DRTSW traded down $0.01 during trading on Friday, reaching $2.69. 12,163 shares of the company traded hands, compared to its average volume of 63,321. Alpha Tau Medical has a 52-week low of $0.20 and a 52-week high of $4.28. The business’s fifty day moving average is $2.69 and its 200-day moving average is $1.68.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.